Nuveen Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $205M | Buy |
625,879
+10,367
| +2% | +$3.4M | 0.06% | 253 |
|
|
2024
Q3 | $185M | Sell |
615,512
-11,907
| -2% | -$3.57M | 0.05% | 282 |
|
|
2024
Q2 | $207M | Buy |
627,419
+75,502
| +14% | +$24.9M | 0.06% | 243 |
|
|
2024
Q1 | $218M | Buy |
551,917
+97,678
| +22% | +$38.7M | 0.06% | 249 |
|
|
2023
Q4 | $160M | Buy |
454,239
+6,952
| +2% | +$2.45M | 0.05% | 294 |
|
|
2023
Q3 | $168M | Buy |
447,287
+21,293
| +5% | +$7.99M | 0.06% | 256 |
|
|
2023
Q2 | $163M | Buy |
425,994
+38,855
| +10% | +$14.9M | 0.06% | 275 |
|
|
2023
Q1 | $134M | Sell |
387,139
-118,640
| -23% | -$41.1M | 0.05% | 306 |
|
|
2022
Q4 | $119M | Sell |
505,779
-180,515
| -26% | -$42.5M | 0.05% | 335 |
|
|
2022
Q3 | $169M | Buy |
686,294
+59,376
| +9% | +$14.6M | 0.07% | 257 |
|
|
2022
Q2 | $190M | Sell |
626,918
-88,377
| -12% | -$26.7M | 0.07% | 249 |
|
|
2022
Q1 | $295M | Buy |
715,295
+14,292
| +2% | +$5.9M | 0.1% | 200 |
|
|
2021
Q4 | $329M | Sell |
701,003
-26,849
| -4% | -$12.6M | 0.1% | 194 |
|
|
2021
Q3 | $309M | Sell |
727,852
-66,251
| -8% | -$28.1M | 0.1% | 200 |
|
|
2021
Q2 | $285M | Sell |
794,103
-73,610
| -8% | -$26.4M | 0.09% | 221 |
|
|
2021
Q1 | $245M | Buy |
867,713
+46,270
| +6% | +$13M | 0.08% | 235 |
|
|
2020
Q4 | $233M | Buy |
821,443
+72,908
| +10% | +$20.7M | 0.08% | 223 |
|
|
2020
Q3 | $206M | Sell |
748,535
-2,741
| -0.4% | -$754K | 0.08% | 222 |
|
|
2020
Q2 | $171M | Buy |
751,276
+114,409
| +18% | +$26M | 0.07% | 256 |
|
|
2020
Q1 | $97M | Buy |
636,867
+109,476
| +21% | +$16.7M | 0.05% | 309 |
|
|
2019
Q4 | $79.3M | Buy |
527,391
+46,649
| +10% | +$7.01M | 0.03% | 477 |
|
|
2019
Q3 | $68.2M | Buy |
480,742
+176,994
| +58% | +$25.1M | 0.03% | 522 |
|
|
2019
Q2 | $38M | Buy |
+303,748
| New | +$38M | 0.02% | 823 |
|
|
2017
Q2 | – | Sell |
-6,515
| Closed | -$532K | – | 1314 |
|
|
2017
Q1 | $532K | Sell |
6,515
-6,947
| -52% | -$567K | ﹤0.01% | 1143 |
|
|
2016
Q4 | $1.14M | Sell |
13,462
-16,408
| -55% | -$1.39M | 0.01% | 1093 |
|
|
2016
Q3 | $2.23M | Hold |
29,870
| – | – | 0.01% | 740 |
|
|
2016
Q2 | $2.27M | Sell |
29,870
-101
| -0.3% | -$7.67K | 0.01% | 694 |
|
|
2016
Q1 | $2.08K | Buy |
29,971
+1,940
| +7% | +$135 | 0.01% | 724 |
|
|
2015
Q4 | $1.69K | Buy |
28,031
+342
| +1% | +$21 | 0.01% | 831 |
|
|
2015
Q3 | $1.5K | Buy |
27,689
+22,368
| +420% | +$1.21K | 0.01% | 883 |
|
|
2015
Q2 | $309 | Sell |
5,321
-159
| -3% | -$9 | ﹤0.01% | 1372 |
|
|
2015
Q1 | $330K | Hold |
5,480
| – | – | ﹤0.01% | 1358 |
|
|
2014
Q4 | $292K | Sell |
5,480
-284
| -5% | -$15.1K | ﹤0.01% | 1405 |
|
|
2014
Q3 | $258K | Hold |
5,764
| – | – | ﹤0.01% | 1391 |
|
|
2014
Q2 | $243K | Hold |
5,764
| – | – | ﹤0.01% | 1434 |
|
|
2014
Q1 | $254K | Hold |
5,764
| – | – | ﹤0.01% | 1413 |
|
|
2013
Q4 | $283K | Buy |
+5,764
| New | +$283K | ﹤0.01% | 1350 |
|